HERCULES, CA--(Marketwire - February 11, 2008) - Bio-Rad Laboratories, Inc. (AMEX: BIO) and (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of the first and only fully automated, random access multiplex test system for autoimmune systemic vasculitis testing. The BioPlex® 2200 Vasculitis kit is for use on the BioPlex 2200 system, a platform that employs multiplexing technology to analyze multiple disease markers from a single patient sample.